Biblio

Export 692 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Humans  [Clear All Filters]
Journal Article
A. Shafir, Ritchie, C. S., Garrett, S. B., Sideman, A. Bernstein, Naasan, G., Merrilees, J., Widera, E., Flint, L., and Harrison, K. L., "Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic., J Alzheimers Dis, vol. 86, no. 2, pp. 787-800, 2022.
K. Ding, Tarumi, T., Zhu, D. C., Tseng, B. Y., Thomas, B. P., Turner, M., Repshas, J., Kerwin, D. R., Womack, K. B., Lu, H., C Cullum, M., and Zhang, R., Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment., J Alzheimers Dis, vol. 61, no. 2, pp. 729-739, 2018.
E. Rotondo, Galimberti, D., Mercurio, M., Giardinieri, G., Forti, S., Vimercati, R., Borracci, V., Fumagalli, G. G., Pietroboni, A. M., Carandini, T., Nobili, A., Scarpini, E., and Arighi, A., Caregiver Tele-Assistance for Reduction of Emotional Distress During the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience., J Alzheimers Dis, vol. 85, no. 3, pp. 1045-1052, 2022.
M. A. Burguillos, Deierborg, T., Kavanagh, E., Persson, A., Hajji, N., Garcia-Quintanilla, A., Cano, J., Brundin, P., Englund, E., Venero, J. L., and Joseph, B., Caspase signalling controls microglia activation and neurotoxicity., Nature, vol. 472, no. 7343, pp. 319-24, 2011.
S. Chu, Xu, F., Su, Y., Chen, H., and Cheng, X., Cerebral Amyloid Angiopathy (CAA)-Related Inflammation: Comparison of Inflammatory CAA and Amyloid-β-Related Angiitis., J Alzheimers Dis, vol. 51, no. 2, pp. 525-32, 2016.
N. Wang, Allali, G., Kesavadas, C., Noone, M. L., Pradeep, V. G., Blumen, H. M., and Verghese, J., Cerebral Small Vessel Disease and Motoric Cognitive Risk Syndrome: Results from the Kerala-Einstein Study., J Alzheimers Dis, vol. 50, no. 3, pp. 699-707, 2016.
S. Chaudhary, Zhornitsky, S., Chao, H. H., van Dyck, C. H., and Li, C. - S. R., Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort., J Alzheimers Dis, vol. 85, no. 3, pp. 1251-1265, 2022.
D. Renard, Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Le Floch, A., Bouly, S., Marelli, C., Arquizan, C., Hirtz, C., Gabelle, A., Thouvenot, E., and Lehmann, S., Cerebrospinal Fluid Alzheimer's Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 3, pp. 759-64, 2016.
D. - W. Chen, Wang, J., Zhang, L. - L., Wang, Y. - J., and Gao, C. - Y., Cerebrospinal Fluid Amyloid-β Levels are Increased in Patients with Insomnia., J Alzheimers Dis, vol. 61, no. 2, pp. 645-651, 2018.
M. Carmona-Iragui, Fernández-Arcos, A., Alcolea, D., Piazza, F., Morenas-Rodriguez, E., Antón-Aguirre, S., Sala, I., Clarimón, J., Dols-Icardo, O., Camacho, V., Sampedro, F., Munuera, J., Nuñez-Marin, F., Lleo, A., Fortea, J., Gómez-Ansón, B., and Blesa, R., Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
A. Kimura, Yoshikura, N., Hayashi, Y., and Inuzuka, T., Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 2, pp. 581-588, 2018.
M. Bjerke, Kern, S., Blennow, K., Zetterberg, H., Waern, M., Börjesson-Hanson, A., Östling, S., Kern, J., and Skoog, I., Cerebrospinal Fluid Fatty Acid-Binding Protein 3 is Related to Dementia Development in a Population-Based Sample of Older Adult Women Followed for 8 Years., J Alzheimers Dis, vol. 49, no. 3, pp. 733-41, 2016.
P. Buchhave, Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., and Hansson, O., Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia., Arch Gen Psychiatry, vol. 69, no. 1, pp. 98-106, 2012.
K. E. Melah, Lu, S. Yuan- Fu, Hoscheidt, S. M., Alexander, A. L., Adluru, N., Destiche, D. J., Carlsson, C. M., Zetterberg, H., Blennow, K., Okonkwo, O. C., Gleason, C. E., N Dowling, M., Bratzke, L. C., Rowley, H. A., Sager, M. A., Asthana, S., Johnson, S. C., and Bendlin, B. B., Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 3, pp. 873-86, 2016.
D. Renard, Collombier, L., Demattei, C., Wacongne, A., Charif, M., Ayrignac, X., Azakri, S., Gaillard, N., Boudousq, V., Lehmann, S., de Champfleur, N. Menjot, and Thouvenot, E., Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation., J Alzheimers Dis, vol. 61, no. 3, pp. 1107-1117, 2018.
G. Novak, Fox, N., Clegg, S., Nielsen, C., Einstein, S., Lu, Y., Tudor, I. Cristina, Gregg, K., Di, J., Collins, P., Wyman, B. T., Yuen, E., Grundman, M., H Brashear, R., and Liu, E., Changes in Brain Volume with Bapineuzumab in Mild to Moderate Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 4, pp. 1123-34, 2016.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders., J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
J. R. Hall, Wiechmann, A., Johnson, L. A., Edwards, M., and O'Bryant, S. E., Characteristics of Cognitively Normal Mexican-Americans with Cognitive Complaints., J Alzheimers Dis, vol. 61, no. 4, pp. 1485-1492, 2018.
M. Kleinschmidt, Schoenfeld, R., Göttlich, C., Bittner, D., Metzner, J. Erich, Leplow, B., and Demuth, H. - U., Characterizing Aging, Mild Cognitive Impairment, and Dementia with Blood-Based Biomarkers and Neuropsychology., J Alzheimers Dis, vol. 50, no. 1, pp. 111-26, 2016.
A. Madhavan, Schwarz, C. G., Duffy, J. R., Strand, E. A., Machulda, M. M., Drubach, D. A., Kantarci, K., Przybelski, S. A., Reid, R. I., Senjem, M. L., Gunter, J. L., Apostolova, L. G., Lowe, V. J., Petersen, R. C., Jack, C. R., Josephs, K. A., and Whitwell, J. L., Characterizing White Matter Tract Degeneration in Syndromic Variants of Alzheimer's Disease: A Diffusion Tensor Imaging Study., J Alzheimers Dis, vol. 49, no. 3, pp. 633-43, 2016.
H. - L. Wang, Wang, Y. - Y., Liu, X. - G., Kuo, S. - H., Liu, N., Song, Q. - Y., and Wang, M. - W., Cholesterol, 24-Hydroxycholesterol, and 27-Hydroxycholesterol as Surrogate Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis., J Alzheimers Dis, vol. 51, no. 1, pp. 45-55, 2016.
X. Zhang, Cai, X., Shi, X., Zheng, Z., Zhang, A., Guo, J., and Fang, Y., Chronic Obstructive Pulmonary Disease as a Risk Factor for Cognitive Dysfunction: A Meta-Analysis of Current Studies., J Alzheimers Dis, vol. 52, no. 1, pp. 101-11, 2016.
S. Tran, Kuruppu, S., and Rajapakse, N. W., Chronic Renin-Angiotensin System Activation Induced Neuroinflammation: Common Mechanisms Underlying Hypertension and Dementia?, J Alzheimers Dis, vol. 85, no. 3, pp. 943-955, 2022.
H. Qiu, Zhong, R., Liu, H., Zhang, F., Li, S., and Le, W., Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice., J Alzheimers Dis, vol. 50, no. 3, pp. 669-85, 2016.
K. R. LeVault, Tischkau, S. A., and Brewer, G. J., Circadian Disruption Reveals a Correlation of an Oxidative GSH/GSSG Redox Shift with Learning and Impaired Memory in an Alzheimer's Disease Mouse Model., J Alzheimers Dis, vol. 49, no. 2, pp. 301-16, 2016.

Pages